DK58291D0 - Krystalinsk stof og dets fremstilling - Google Patents

Krystalinsk stof og dets fremstilling

Info

Publication number
DK58291D0
DK58291D0 DK91582A DK58291A DK58291D0 DK 58291 D0 DK58291 D0 DK 58291D0 DK 91582 A DK91582 A DK 91582A DK 58291 A DK58291 A DK 58291A DK 58291 D0 DK58291 D0 DK 58291D0
Authority
DK
Denmark
Prior art keywords
preparation
crystaline material
crystaline
compositions containing
same
Prior art date
Application number
DK91582A
Other languages
Danish (da)
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK91582A priority Critical patent/DK58291D0/da
Publication of DK58291D0 publication Critical patent/DK58291D0/da
Priority to DE69229339T priority patent/DE69229339T2/de
Priority to AU16415/92A priority patent/AU661483B2/en
Priority to ES92908325T priority patent/ES2134801T3/es
Priority to EP92908325A priority patent/EP0579681B1/fr
Priority to DK92908325T priority patent/DK0579681T3/da
Priority to JP4-507965A priority patent/JP3001975B2/ja
Priority to AT92908325T priority patent/ATE180781T1/de
Priority to CA002107223A priority patent/CA2107223C/fr
Priority to PCT/DK1992/000093 priority patent/WO1992017473A1/fr
Priority to IL10135892A priority patent/IL101358A/en
Priority to US07/857,038 priority patent/US5354760A/en
Priority to ZA922297A priority patent/ZA922297B/xx
Priority to NZ24219192A priority patent/NZ242191A/en
Priority to FI934298A priority patent/FI110096B/fi
Priority to NO933524A priority patent/NO304113B1/no
Priority to GR990402003T priority patent/GR3030919T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91582A 1991-04-02 1991-04-02 Krystalinsk stof og dets fremstilling DK58291D0 (da)

Priority Applications (17)

Application Number Priority Date Filing Date Title
DK91582A DK58291D0 (da) 1991-04-02 1991-04-02 Krystalinsk stof og dets fremstilling
PCT/DK1992/000093 WO1992017473A1 (fr) 1991-04-02 1992-03-23 Monohydrate d'hydrochlorure de tiagabine cristalline, sa preparation et son utilisation
JP4-507965A JP3001975B2 (ja) 1991-04-02 1992-03-23 結晶性チアガビン塩酸塩−水和物、その製造方法および用途
CA002107223A CA2107223C (fr) 1991-04-02 1992-03-23 Chlorhydrate de tiagabine monohydrate cristallin, sa preparation et son utilisation
ES92908325T ES2134801T3 (es) 1991-04-02 1992-03-23 Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
EP92908325A EP0579681B1 (fr) 1991-04-02 1992-03-23 Monohydrate d'hydrochlorure de tiagabine cristalline, sa preparation et son utilisation
DK92908325T DK0579681T3 (da) 1991-04-02 1992-03-23 Krystallinsk tiagabin-hydrochlorid-monohydrat, dets fremstilling og dets anvendelse
DE69229339T DE69229339T2 (de) 1991-04-02 1992-03-23 Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
AT92908325T ATE180781T1 (de) 1991-04-02 1992-03-23 Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
AU16415/92A AU661483B2 (en) 1991-04-02 1992-03-23 Crystalline tiagabine hydrochloride monohydrate, its preparation and use
US07/857,038 US5354760A (en) 1991-04-02 1992-03-24 Crystalline Tiagabine monohydrate, its preparation and use
IL10135892A IL101358A (en) 1991-04-02 1992-03-24 Tiagabine hydrochloride crystalline monohydrate, its preparation and pharmaceutical preparations containing the same
ZA922297A ZA922297B (en) 1991-04-02 1992-03-30 Crystalline tiababine monohydrate,its preparation and use
NZ24219192A NZ242191A (en) 1991-04-02 1992-04-01 Crystalline tiagabine hydrochloride monohydrate, preparation and pharmaceutical compositions thereof
FI934298A FI110096B (fi) 1991-04-02 1993-09-30 Menetelmä terapeuttisesti käyttökelpoisen kiteisen Tiagabine-hydrokloridimonohydraatin valmistamiseksi
NO933524A NO304113B1 (no) 1991-04-02 1993-10-01 Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament
GR990402003T GR3030919T3 (en) 1991-04-02 1999-08-04 Selective system scan for multizone radiotelephone subscriber units.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK91582A DK58291D0 (da) 1991-04-02 1991-04-02 Krystalinsk stof og dets fremstilling

Publications (1)

Publication Number Publication Date
DK58291D0 true DK58291D0 (da) 1991-04-02

Family

ID=8095193

Family Applications (2)

Application Number Title Priority Date Filing Date
DK91582A DK58291D0 (da) 1991-04-02 1991-04-02 Krystalinsk stof og dets fremstilling
DK92908325T DK0579681T3 (da) 1991-04-02 1992-03-23 Krystallinsk tiagabin-hydrochlorid-monohydrat, dets fremstilling og dets anvendelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK92908325T DK0579681T3 (da) 1991-04-02 1992-03-23 Krystallinsk tiagabin-hydrochlorid-monohydrat, dets fremstilling og dets anvendelse

Country Status (15)

Country Link
US (1) US5354760A (fr)
EP (1) EP0579681B1 (fr)
AT (1) ATE180781T1 (fr)
AU (1) AU661483B2 (fr)
CA (1) CA2107223C (fr)
DE (1) DE69229339T2 (fr)
DK (2) DK58291D0 (fr)
ES (1) ES2134801T3 (fr)
FI (1) FI110096B (fr)
GR (1) GR3030919T3 (fr)
IL (1) IL101358A (fr)
NO (1) NO304113B1 (fr)
NZ (1) NZ242191A (fr)
WO (1) WO1992017473A1 (fr)
ZA (1) ZA922297B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750140A (en) * 1994-05-20 1998-05-12 Novo Nordisk A/S Transdermal delivery of tiagabine
PL183678B1 (pl) * 1995-05-05 2002-06-28 Novo Nordisk As Środek farmaceutyczny zawierający tiagabinę i sposób wytwarzania środka farmaceutycznego zawierającego tiagabinę
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
AU736514B2 (en) * 1995-07-13 2001-07-26 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Non-allosteric gabaa agonists for treating sleep disorders
UA52661C2 (uk) * 1996-06-14 2003-01-15 Ново Нордіск А/С Безводна кристалічна форма гідрохлориду r(-)-n-(4,4-ди(3-метилтієн-2-іл)бут-3-еніл) ніпекотинової кислоти
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
US6410520B2 (en) 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
EP2316468A1 (fr) 2002-02-22 2011-05-04 Shire LLC Système de distribution et méthodes de protection et d'administration de dextroamphetamine
CN1314684C (zh) * 2003-12-24 2007-05-09 中国科学院上海有机化学研究所 噻加宾及其消旋体和s－构型的合成方法及其无定形粉末的制法
WO2005122698A2 (fr) * 2003-12-24 2005-12-29 Sun Pharmaceutical Industries Limited Nouvelles formes polymorphes stables d'un anticonvulsif
WO2005092886A1 (fr) * 2004-03-29 2005-10-06 Ranbaxy Laboratories Limited Procede de preparation d'une forme amorphe de la tiagabine
US20080269495A1 (en) * 2004-08-04 2008-10-30 Prosenjit Bose Process for Preparation of Piperidine Carboxylic Acid
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US20080064727A1 (en) * 2006-08-18 2008-03-13 Cephalon, Inc. Crystalline forms of tiagabine hydrochloride
US20080051435A1 (en) * 2006-08-18 2008-02-28 Cephalon, Inc. Crystalline and amorphous forms of tiagabine
CN101857591B (zh) * 2009-04-09 2013-06-05 北京京卫燕康药物研究所有限公司 盐酸噻加宾晶型及其制备方法
CN103554093B (zh) * 2013-11-12 2015-10-21 四川科瑞德凯华制药有限公司 噻加宾乙酯盐酸盐及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof

Also Published As

Publication number Publication date
WO1992017473A1 (fr) 1992-10-15
ATE180781T1 (de) 1999-06-15
GR3030919T3 (en) 1999-11-30
CA2107223C (fr) 2005-02-15
NO304113B1 (no) 1998-10-26
NO933524L (no) 1993-10-01
NZ242191A (en) 1994-07-26
IL101358A (en) 1996-08-04
DE69229339T2 (de) 1999-12-30
AU1641592A (en) 1992-11-02
ES2134801T3 (es) 1999-10-16
US5354760A (en) 1994-10-11
JPH06506209A (ja) 1994-07-14
EP0579681B1 (fr) 1999-06-02
ZA922297B (en) 1992-12-30
EP0579681A1 (fr) 1994-01-26
AU661483B2 (en) 1995-07-27
FI110096B (fi) 2002-11-29
IL101358A0 (en) 1992-11-15
FI934298A (fi) 1993-09-30
DK0579681T3 (da) 1999-11-15
FI934298A0 (fi) 1993-09-30
DE69229339D1 (de) 1999-07-08
NO933524D0 (no) 1993-10-01
CA2107223A1 (fr) 1992-10-03

Similar Documents

Publication Publication Date Title
DK58291D0 (da) Krystalinsk stof og dets fremstilling
ATE255589T1 (de) Kristallin form i von clarithromycin
TW272195B (fr)
PL307914A1 (en) Lipopetide derivatives, method of obtaining them and therapeutic agents containing such compounds
NO304983B1 (no) Nye fosfinyloksymetylketoner, farmas°ytisk sammensetning og anvendelse derav
DK0435333T3 (da) Cephalosporinderivater, fremgangsmåde til fremstilling deraf og antimikrobielt præparat indeholdende derivaterne
IL99471A0 (en) Pharmaceutical compositions containing pyridylmethylsulphinyl-1h-benzimidazole derivatives as active ingredient therein
IL109866A0 (en) Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (+) l-hydrogentartrate, its preparation and pharmaceutical compositions containing it
IL85425A (en) Anticonvulsant compositions containing substituted benzoyl anilides, some such novel compounds and process for their preparation
FI923751A (fi) Hexahydrobenso/f/kinolinoner
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents
IT1255678B (it) Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale.
ITMI911343A0 (it) Composizioni farmaceutiche per il trattamento di dermatosi
UA23046C2 (uk) Протимікробhий засіб

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment